These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30937413)
1. Decreasing Door-to-Door Times for Infliximab Infusions in a Children's Hospital Observation Unit. Sandberg KC; Lucien JN; Stoll D; Yanney E; Mezoff A Pediatr Qual Saf; 2019; 4(1):e131. PubMed ID: 30937413 [TBL] [Abstract][Full Text] [Related]
2. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability. Bohra A; Rizvi QA; Keung CYY; Vasudevan A; van Langenberg DR World J Gastroenterol; 2020 Sep; 26(36):5437-5449. PubMed ID: 33024395 [TBL] [Abstract][Full Text] [Related]
3. A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol. Ong WC; Lim MS; Chan E; Lim TCT; Lim TG; Chan W JGH Open; 2022 Jul; 6(7):470-476. PubMed ID: 35822121 [TBL] [Abstract][Full Text] [Related]
4. Are accelerated infliximab infusions safe in patients with inflammatory bowel disease? Bhat S; Sharma D; Doherty P; Tham TC; Caddy GR Inflamm Bowel Dis; 2010 Nov; 16(11):1922-5. PubMed ID: 20848465 [TBL] [Abstract][Full Text] [Related]
5. A home infliximab infusion program. Condino AA; Fidanza S; Hoffenberg EJ J Pediatr Gastroenterol Nutr; 2005 Jan; 40(1):67-9. PubMed ID: 15625429 [TBL] [Abstract][Full Text] [Related]
7. The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease. Qazi T; Shah B; El-Dib M; Farraye FA Dig Dis Sci; 2016 Feb; 61(2):589-96. PubMed ID: 26441281 [TBL] [Abstract][Full Text] [Related]
8. Impact of rapid infliximab infusions on access at a large academic tertiary medical center. Pusateri A; Hatcher A; Patel N; Lehman J; Hinton A; Afzali A Am J Health Syst Pharm; 2021 Nov; 78(22):2046-2052. PubMed ID: 34050749 [TBL] [Abstract][Full Text] [Related]
9. Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study. Van Assche G; Vermeire S; Noman M; Amant C; Weyts E; Vleminckx A; Vermeyen MJ; Rutgeerts P J Crohns Colitis; 2010 Sep; 4(3):329-33. PubMed ID: 21122522 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population. Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416 [TBL] [Abstract][Full Text] [Related]
11. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632 [TBL] [Abstract][Full Text] [Related]
12. Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study. Abushamma S; Walker T; Garza K; Chen L; Nix D; Chen CH Crohns Colitis 360; 2023 Jul; 5(3):otad022. PubMed ID: 37288326 [TBL] [Abstract][Full Text] [Related]
13. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases. Giese-Kim N; Wu M; Dehghan M; Sceats LA; Park KT Am J Gastroenterol; 2020 Oct; 115(10):1698-1706. PubMed ID: 32701731 [TBL] [Abstract][Full Text] [Related]
14. The extra burden of infliximab infusions in inflammatory bowel disease. Buisson A; Seigne AL; Dʼhuart MC; Bigard MA; Peyrin-Biroulet L Inflamm Bowel Dis; 2013 Oct; 19(11):2464-7. PubMed ID: 23942563 [TBL] [Abstract][Full Text] [Related]
15. Tolerability of one hour 10 mg/kg infliximab infusions in patients with inflammatory bowel disease. Babouri A; Buisson A; Bigard MA; Peyrin-Biroulet L J Crohns Colitis; 2013 Mar; 7(2):129-33. PubMed ID: 22472090 [TBL] [Abstract][Full Text] [Related]